IP Library Patent Application 18247007
Patent Application
App. No. 18/247,007

1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AS INHIBITORS OF THE YAP/TAZ-TEAD ACTIVATION FOR TREATING CANCER

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/247,007
Abstract

The present invention relates to novel compounds of formula (Ia), to said compounds for use as a medicine, more in particular for the prevention or treatment of diseases mediated by activity of YAP/TAZ-TEAD transcription, yet more in particular for the prevention or treatment of cancer or fibrosis. The present invention also relates to a method for the prevention or treatment of said diseases comprising the use of the novel compounds. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds as well as to said compositions or preparations for use as a medicine, more preferably for the prevention or treatment of diseases mediated by activity of YAP/TAZ-TEAD transcription, yet more in particular for the prevention or treatment of cancer or fibrosis. The present invention also relates to processes for the preparation of said compounds.

Claims (95)

1 . A compound of Formula (Ia), or an isomer (preferably a stereo-isomer or a tautomer), a solvate, a salt (preferably a pharmaceutically acceptable salt) or a prodrug thereof, preferably a pharmaceutically acceptable salt, solvate, hydrate, polymorph, tautomer, stereoisomer, or prodrug thereof,

wherein:

E is selected from (5-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, trifluoromethyl, —O—C 1-6 alkyl, —OCF 3 , cyano, nitro, —C(O)OH, —C(O)OC 1-6 alkyl, —C(O)C 1-6 alkyl, —CONH 2 , —CONHC 1-6 alkyl, —CON(C 1-6 alkyl) 2 , —SO 2 C 1-6 alkyl, —SO 2 NH 2 , —SO 2 NHC 1-6 alkyl, —SO 2 N(C 1-6 alkyl) 2 , —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(NH)(NH)C 1-6 alkyl, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ; and —(CR 10a R 10b ) n —NR 1 R 2 ;

n is selected from 0; 1; and 2;

m is selected from 0; and 1;

each — represents an optional double bond, whereby maximally 3 —are a double bond at the same time;

R 1 is selected from C 1-6 alkyl; C 3-9 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; —C(O)H; —C(O)R 3 ; —C(O)OR 4 ; —C(O)NR 5 R 6 ; —S(O) 2 R 3a ; —S(O)R 4a ; —S(O) 2 NR 5a R 6a ; —S(O)(NR 5a )R 4a ; —S(NR 5a )(NR 6a )R 3a ; and —P(O)R 5b R 6b ;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, trifluoromethyl, —O—C 1-6 alkyl, —OCF 3 , cyano, nitro, —C(O)OH, —C(O)OC 1-6 alkyl, —C(O)C 1-6 alkyl, —CONH 2 , —CONHC 1-6 alkyl, —CON(C 1-6 alkyl) 2 , —SO 2 C 1-6 alkyl, —SO 2 NH 2 , —SO 2 NHC 1-6 alkyl, —SO 2 N(C 1-6 alkyl) 2 , —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(NH)(NH)C 1-6 alkyl, —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(O) 2 OH, —S(NH)(NH)C 1-6 alkyl, —NH 2 , —NHC 1-6 alkyl, —N(C 1-6 alkyl) 2 ;

R 2 is selected from hydrogen; C 1-6 alkyl; C 3-9 cycloalkyl; and C 1-6 heteroalkyl;

R 1 and R 2 can be taken together to form a (4-; 5-; 6- or 7-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, trifluoromethyl, —O—C 1-6 alkyl, —OCF 3 , cyano, nitro, —C(O)OH, —C(O)OC 1-6 alkyl, —C(O)C 1-6 alkyl, —CONH 2 , —CONHC 1-6 alkyl, —CON(C 1-6 alkyl) 2 , —SO 2 C 1-6 alkyl, —SO 2 NH 2 , —SO 2 NHC 1-6 alkyl, —SO 2 N(C 1-6 alkyl) 2 , —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(NH)(NH)C 1-6 alkyl, —NH 2 , —NHC 1-6 alkyl, —N(C 1-6 alkyl) 2 ;

each R 3 and R 3a is independently selected from hydroxyl; C 1-6 alkyl; C 3-9 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; and C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

each R 4 and R 4a is independently selected from C 1-6 alkyl; C 3-9 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; and C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

each R 5 , R 5a , R 5b , R 5 , R 5a and R 5b is independently selected from hydrogen; C 1-6 alkyl; C 3-6 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; and C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

and wherein each R 5 and R 6 or R 5a and R 6a can be taken together in order to form a (4-, 5-, 6-, or 7-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O— alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

cycle A is selected from aryl; heteroaryl; C 3-9 cycloalkyl; and heterocycle;

wherein said aryl, heteroaryl, C 3-9 cycloalkyl and heterocycle is substituted with one or more R 7 ;

each R 7 is independently selected from halogen; hydroxyl; sulfhydryl; ═O; ═S; —OZ 1 ; —SZ 1 ; —SCF 3 ; —SF 5 ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; —NZ 3 Z 4 ; —NZ 3 C(O)Z 1 ; cyano; —C(O)Z 2 ; —C(O)OZ 1 ; —C(O)NZ 3 Z 4 ; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylalkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

X 1 is selected from CR 8 ; N; and NR 8a ; whereby X 1 can only be NR 6a when X 2 and/or X 4 are C═O or C═S;

X 2 is selected from CR 9 ; N; and NR 5a ; whereby X 2 can only be NR 9a when X 1 and/or X 3 are C═O or C—SH;

X 3 is selected from CH; and N;

X 4 is selected from CH; and N;

X 5 is selected from —S(═O) 2 —; —C(═O)—; and —CH 2 —;

each R 10a is independently selected from hydrogen; and C 1-4 alkyl;

each R 10b is independently selected from hydrogen; and C 1-4 alkyl

wherein said alkyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

whereby maximally 2 of X 1 , X 2 , X 3 and X 4 can be a N (selected from N and NR 8a for X 1 , from N and NR 9a for X 2 , from N for X 3 , and from N for X 4 respectively) at the same time;

provided that at least one of R 8 and R 9 is not hydrogen, each R 8 and R 9 are independently selected from hydrogen; halogen; hydroxyl; sulfhydryl; ═O; ═S; —OZ 1a ; —SZ 1a ; —SCF 3 ; —SF 5 ; —S(O)Z 1a ; —S(O)(NZ 3a )Z 1a ; —S(NZ 3a )(NZ 3a )Z 1a ; —S(O) 2 Z 2a ; —S(O) 2 NZ 3a Z 4a ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; nitro; —NZ 3a Z 4a ; —NZ 3a S(O) 2 Z 1a ; —NZ 3a C(O)Z 1a ; —NZ 3a C(O)NZ 3a Z 4 a cyano; —C(O)Z 2a ; —C(O)OZ 1a ; —C(O)NZ 3a Z 4a ; —C(O)H; —P(O)Z 3a Z 4a ; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each R 8a and R 9a are independently selected from hydrogen; hydroxyl; sulfhydryl; —OZ 1a ; —SZ 1a ; —SCF 3 ; —SF 5 ; —S(O)Z 1a ; —S(O)(NZ 3a )Z 1a ; —S(NZ 3a )(NZ 3a )Z 1a ; —S(O) 2 Z 2a ; —S(O) 2 NZ 3a Z 4a ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; nitro; —NZ 3a Z 4a ; —NZ 3a S(O) 2 Z 2a ; —NZ 3a C(O)Z 1a ; —NZ 3a C(O)NZ 3a Z 4a ; cyano; —C(O)Z 2a ; —C(O)OZ 1a ; —C(O)NZ 3a Z 4a ; —C(O)H; —P(O)Z 3a Z 4a ; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each Z 1 and Z 1a is independently selected from C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylC 2-6 alkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl, and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each Z 2 and Z 2a is independently selected from hydroxyl; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylC 2-6 alkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl, and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each Z 3 , Z 3a , Z 4 , and Z 4a is independently selected from hydrogen; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylC 2-6 alkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl, and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

and wherein each Z 3 and Z 4 or Z 3a and Z 4a can be taken together in order to form a (4-, 5-, 6-, or 7-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 .

2 . A compound of formula (I), or an isomer (preferably a stereo-isomer or a tautomer), a solvate, a salt (preferably a pharmaceutically acceptable salt) or a prodrug thereof, preferably a pharmaceutically acceptable salt, solvate, hydrate, polymorph, tautomer, stereoisomer, or prodrug thereof,

wherein:

n is selected from 0; 1; and 2;

each — represents an optional double bond, whereby maximally 3 —are a double bond at the same time;

R 1 is selected from C 1-6 alkyl; C 3-9 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; —C(O)H; —C(O)R 3 ; —C(O)OR 4 ; —C(O)NR 5 R 6 ; —S(O) 2 R 3a ; —S(O)R 4a ; —S(O) 2 NR 5a R 6a ; —S(O)(NR 5a )R 4a ; —S(NR 5a )(NR 6a )R 3a ; and —P(O)R 5b R 6b ;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, trifluoromethyl, —O—C 1-6 alkyl, —OCF 3 , cyano, nitro, —C(O)OH, —C(O)OC 1-6 alkyl, —C(O)C 1-6 alkyl, —CONH 2 , —CONHC 1-6 alkyl, —CON(C 1-6 alkyl) 2 , —SO 2 C 1-6 alkyl, —SO 2 NH 2 , —SO 2 NHC 1-6 alkyl, —SO 2 N(C 1-6 alkyl) 2 , —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(NH)(NH)C 1-6 alkyl, —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(NH)(NH)C 1-6 alkyl, —NH 2 , —NHC 1-6 alkyl, —N(C 1-6 alkyl) 2 ;

R 2 is selected from hydrogen; C 1-6 alkyl; C 3-9 cycloalkyl; and C 1-6 heteroalkyl;

R 1 and R 2 can be taken together to form a (4-; 5-; 6- or 7-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, trifluoromethyl, —O—C 1-6 alkyl, —OCF 3 , cyano, nitro, —C(O)OH, —C(O)OC 1-6 alkyl, —C(O)C 1-6 alkyl, —CONH 2 , —CONHC 1-6 alkyl, —CON(C 1-6 alkyl) 2 , —SO 2 C 1-6 alkyl, —SO 2 NH 2 , —SO 2 NHC 1-6 alkyl, —SO 2 N(C 1-6 alkyl) 2 , —S(O)(NH)C 1-6 alkyl, —S(O)(NC 1-6 alkyl)C 1-6 alkyl, —S(NH)(NH)C 1-6 alkyl, —NH 2 , —NHC 1-6 alkyl, —N(C 1-6 alkyl) 2 ;

each R 3 and R 3a is independently selected from hydroxyl; C 1-6 alkyl; C 3-9 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; and C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

each R 4 and R 4a is independently selected from C 1-6 alkyl; C 3-9 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; and C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

each R 5 , R 5 , R 5b , R 6 , R 6a and R 6b is independently selected from hydrogen; C 1-6 alkyl; C 3-6 cycloalkyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; and C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl and C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

and wherein each R 5 and R 6 or R 5a and R 6a can be taken together in order to form a (4-, 5-, 6-, or 7-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O— alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 ;

cycle A is selected from aryl; heteroaryl; C 3-9 cycloalkyl; and heterocycle;

wherein said aryl, heteroaryl, C 3-9 cycloalkyl and heterocycle is substituted with one or more R 7 ;

each R 7 is independently selected from halogen; hydroxyl; sulfhydryl; ═O; ═S; —OZ 1 ; —SZ 1 ; —SCF 3 ; —SF 5 ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; —NZ 3 Z 4 ; —NZ 3 C(O)Z 1 ; cyano; —C(O)Z 2 ; —C(O)OZ 1 ; —C(O)NZ 3 Z 4 ; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylalkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

X 1 is selected from CR 8 ; N; and NR 8a ; whereby X 1 can only be NR 8a when X 2 and/or X 4 are C═O or C═S;

X 2 is selected from CR 9 ; N; and NR 9a ; whereby X 2 can only be NR 9a when X 1 and/or X 3 are C═O or C—SH;

X 3 is selected from CH; and N;

X 4 is selected from CH; and N;

whereby maximally 2 of X 1 , X 2 , X 3 and X 4 can be a N (selected from N and NR 8a for X 1 , from N and NR 9a for X 2 , from N for X 3 , and from N for X 4 respectively) at the same time;

provided that at least one of R 8 and R 9 is not hydrogen, each R 8 and R 9 are independently selected from hydrogen; halogen; hydroxyl; sulfhydryl; ═O; ═S; —OZ 1a ; —SZ 1a ; —SCF 3 ; —SF 5 ; —S(O)Z 1a ; —S(O)(NZ 3a )Z 1a ; —S(NZ 3a )(NZ 3a )Z 1a ; —S(O) 2 Z 2a ; —S(O) 2 NZ 3a Z 4a ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; nitro; —NZ 3a Z 4a ; —NZ 3a S(O) 2 Z 1a ; —NZ 3a C(O)Z 1a ; —NZ 3a C(O)NZ 3a Z 4 a cyano; —C(O)Z 2a ; —C(O)OZ 1a ; —C(O)NZ 3a Z 4a ; —C(O)H; —P(O)Z 3a Z 4a ; C-alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each R 8a and R 9a are independently selected from hydrogen; hydroxyl; sulfhydryl; —OZ 1a ; —SZ 1a ; —SCF 3 ; —SF 5 ; —S(O)Z 1a ; —S(O)(NZ 3a )Z 1a ; —S(NZ 3a )(NZ 3a )Z 1a ; —S(O) 2 Z 2a ; —S(O) 2 NZ 3a Z 4a ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; nitro; —NZ 3a Z 4a ; —NZ 3a S(O) 2 Z 2a ; —NZ 3a C(O)Z 1a ; —NZ 3a C(O)NZ 3a Z 4a ; cyano; —C(O)Z 2a ; —C(O)OZ 1a ; —C(O)NZ 3a Z 4a ; —C(O)H; —P(O)Z 3a Z 4a ; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each Z 1 and Z 1a is independently selected from C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylC 2-6 alkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl, and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each Z 2 and Z 2a is independently selected from hydroxyl; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylC 2-6 alkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl, and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

each Z 3 , Z 3a , Z 4 , and Z 4a is independently selected from hydrogen; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; C 5-9 cycloalkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, C 5-9 cycloalkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylC 2-6 alkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl, and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 ;

and wherein each Z 3 and Z 4 or Z 3a and Z 4a can be taken together in order to form a (4-, 5-, 6-, or 7-membered) heterocycle which can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH;

NH 2 ; —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2 .

3 . The compound according to claim 1 or 2 , wherein n is 0.

4 . The compound according to claim 1 or 2 , wherein n is 1.

5 . The compound according to claims 1 to 4 , wherein R 1 is selected from —C(O)R 3 ; and —S(O) 2 R 3a .

6 . The compound according to claims 1 to 5 , wherein R 3 and R 3a are independently selected from C 2-6 alkenyl; C 5-9 cycloalkenyl; C 2-6 alkynyl; and C 5-9 cycloalkynyl;

wherein said C 2-6 alkenyl, C 5-9 cycloalkenyl, C 2-6 alkynyl, and C 5-9 cycloalkynyl can be unsubstituted or substituted with one or more substituents selected from alkyl, cycloalkyl, alkenyl, alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O-alkyl, —OCF 3 , —CHF 2 , —OCHF 2 , cyano, nitro, —C(O)OH; NH 2 ; —NHalkyl, and —N(alkyl) 2 .

7 . The compound according to claims 1 to 6 , wherein cycle A is heteroaryl.

8 . The compound according to claims 1 to 6 , wherein cycle A is aryl.

9 . The compound according to claims 1 to 7 , wherein R 8 is selected from hydroxyl; sulfhydryl; —OZ 1a ; —SZ 1a ; —SCF 3 ; —SF 5 ; —S(O)Z 1a ; —S(O)(NZ 3a )Z 1a ; —S(NZ 3a )(NZ 3a )Z 1a ; —S(O) 2 Z 2a ; —S(O) 2 NZ 3a Z 4a ; —CF 3 ; —OCF 3 ; —CHF 2 ; —OCHF 2 ; nitro; —NZ 3a Z 4a ; —NZ 3a S(O) 2 Z 2a ; —NZ 3a C(O)Z 1a ; —NZ 3a C(O)NZ 3a Z 4a ; cyano; —C(O)Z 2a ; —C(O)OZ 1a ; —C(O)NZ 3a Z 4a ; —C(O)H; —P(O)Z 3a Z 4a ; C 1-6 alkyl; C 3-9 cycloakyl; C 2-6 alkenyl; C 2-6 alkynyl; C 1-6 heteroalkyl; C 2-6 heteroalkenyl; C 2-6 heteroalkynyl; aryl; heteroaryl; heterocycle; arylC 1-6 alkyl; arylC 2-6 alkenyl; arylC 2-6 alkynyl; arylC 1-6 heteroalkyl; arylC 2-6 heteroalkenyl; arylC 2-6 heteroalkynyl; heteroarylC 1-6 alkyl; heteroarylC 2-6 alkenyl; heteroarylC 2-6 alkynyl; heteroarylC 1-6 heteroalkyl; heteroarylC 2-6 heteroalkenyl; heteroarylC 2-6 heteroalkynyl; heterocycle-C 1-6 alkyl; heterocycle-C 2-6 alkenyl; heterocycle-C 2-6 alkynyl; heterocycle-C 1-6 heteroalkyl; heterocycle-C 2-6 heteroalkenyl; and heterocycle-C 2-6 heteroalkynyl;

wherein said C 1-6 alkyl, C 3-9 cycloakyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 heteroalkyl, C 2-6 heteroalkenyl, C 2-6 heteroalkynyl, aryl, heteroaryl, heterocycle, arylC 1-6 alkyl, arylC 2-6 alkenyl, arylalkynyl, arylC 1-6 heteroalkyl, arylC 2-6 heteroalkenyl, arylC 2-6 heteroalkynyl, heteroarylC 1-6 alkyl, heteroarylC 2-6 alkenyl, heteroarylC 2-6 alkynyl, heteroarylC 1-6 heteroalkyl, heteroarylC 2-6 heteroalkenyl, heteroarylC 2-6 heteroalkynyl, heterocycle-C 1-6 alkyl, heterocycle-C 2-6 alkenyl, heterocycle-C 2-6 alkynyl, heterocycle-C 1-6 heteroalkyl, heterocycle-C 2-6 heteroalkenyl and heterocycle-C 2-6 heteroalkynyl can be unsubstituted or substituted with one or more substituents selected from C 1-6 alkyl, C 3-9 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, hydroxyl, ═O, halogen, —SH, ═S, —CF 3 , —O—C 1-6 alkyl, —OCF 3 , —CHF 2 ; —OCHF 2 , cyano, nitro, —C(O)OH, —NH 2 , —NHC 1-6 alkyl, and —N(C 1-6 alkyl) 2

10 . A compound, or an isomer (preferably a stereo-isomer or a tautomer), a solvate, a salt (preferably a pharmaceutically acceptable salt) or a prodrug thereof, preferably a pharmaceutically acceptable salt, solvate, hydrate, polymorph, tautomer, stereoisomer, or prodrug thereof, selected from one or more of the compounds of Table 1.

11 . A pharmaceutical composition comprising a pharmaceutically acceptable carrier, and as active ingredient, an effective amount of a compound according to any one of claims 1 to 10 .

12 . The compound according to any one of claims 1 to 10 , or a pharmaceutical composition according to claim 11 , for use as a medicine.

13 . The compound according to any one of claims 1 to 10 , or a pharmaceutical composition according to claim 11 , for use in the prevention or treatment of a YAP/TAZ-TEAD activation mediated disorder in an animal, mammal or human.

14 . The compound according to claim 13 , or a pharmaceutical composition according to claim 11 , wherein the YAP/TAZ-TEAD activation mediated disorders is selected from the group comprising cancer, fibrosis and YAP/TAZ-TEAD activation mediated congenital disorders.

15 . The compound according to claim 13 , or a pharmaceutical composition according to claim 11 , wherein the YAP/TAZ-TEAD activation mediated disorders is selected from lung cancer, breast cancer, head and neck cancer, oesophageal cancer, kidney cancer, bladder cancer, colon cancer, ovarian cancer, cervical cancer, endometrial cancer, liver cancer (including but not limited to cholangiocarcinoma), skin cancer, pancreatic cancer, gastric cancer, brain cancer and prostate cancer, mesotheliomas, and/or sarcomas.

16 . The compound according to claim 13 , or a pharmaceutical composition according to claim 11 , wherein the YAP/TAZ-TEAD activation mediated disorders is selected from acoustic neuroma, acute leukemia, acute lymphocytic leukemia, acute myelocytic leukemia (monocytic, myeloblastic, adenocarcinoma, angiosarcoma, astrocytoma, myelomonocytic and promyelocytic), acute T-cell leukemia, basal cell carcinoma, bile duct carcinoma, bronchogenic carcinoma, chondrosarcoma, chordoma, choriocarcinoma, chronic leukemia, chronic lymphocytic leukemia, chronic myelocytic (granulocytic) leukemia, chronic myelogenous leukemia, colorectal cancer, craniopharyngioma, cystadenocarcinoma, diffuse large B-cell lymphoma, dysproliferative changes (dysplasias and metaplasias), embryonal carcinoma, endometrial cancer, endotheliosarcoma, ependymoma, epithelial carcinoma, erythroleukemia, esophageal cancer, estrogen-receptor positive breast cancer, essential thrombocythemia, Ewing's tumor, fibrosarcoma, follicular lymphoma, germ cell testicular cancer, glioma, glioblastoma, gliosarcoma, heavy chain disease, hemangioblastoma, hepatoma, hepatocellular cancer, hormone insensitive prostate cancer, leiomyosarcoma, leukemia, liposarcoma, lymphagioendotheliosarcoma, lymphangiosarcoma, lymphoblastic leukemia, lymphoma (Hodgkin's and non-Hodgkin's), malignancies and hyperproliferative disorders of the bladder, breast, colon, lung, ovaries, pancreas, prostate, skin and uterus, lymphoid malignancies of T-cell or B-cell origin, medullary carcinoma, medulloblastoma, melanoma, meningioma, mesothelioma, multiple myeloma, myelogenous leukemia, myeloma, myxosarcoma, neuroblastoma, NUT midline carcinoma (NMC), non-small cell lung cancer, oligodendroglioma, oral cancer, osteogenic sarcoma, papillary adenocarcinomas, papillary carcinoma, pinealoma, polycythemia vera, rectal cancer, renal cell carcinoma, retinoblastoma, rhabdomyosarcoma, sarcoma, sebaceous gland carcinoma, seminoma, small cell lung carcinoma, solid tumors (carcinomas and sarcomas), small cell lung cancer, stomach cancer, squamous cell carcinoma, synovioma, sweat gland carcinoma, thyroid cancer, Waldenstrom's macroglobulinemia, testicular tumors, uterine cancer and Wilms' tumor.

17 . A method for the prevention or treatment of a YAP/TAZ-TEAD activation mediated disorders in an animal, mammal or human comprising administering to said animal, mammal or human in need for such prevention or treatment an effective dose of the compounds according to any one of claims 1 to 10 .

18 . A method of treatment or prevention of YAP/TAZ-TEAD activation mediated disorder according to claim 17 to a patient in need thereof in combination with one or more other medicines selected from EGFR inhibitors, MEK inhibitors, AXL inhibitors, B-RAF inhibitors, or RAS inhibitors.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2024
From: MARCHAND, ARNAUD; CANDI, AURELIE; VANDERHOYDONCK, BART; VERSELE, MATTHIAS
To: CISTIM LEUVEN VZW
Reel/Frame 068743/0632 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2024
From: CISTIM LEUVEN VZW
To: KU LEUVEN R&D
Reel/Frame 068742/0960 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2024
From: KATHOLIEKE UNIVERSITEIT LEUVEN
To: KATHOLIEKE UNIVERSITEIT LEUVEN; VIB VZW
Reel/Frame 068743/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2024
From: GWALTNEY, STEPHEN L
To: SPRINGWORKS THERAPEUTICS, INC.
Reel/Frame 068059/0315 →